Chung Min Lee

Title: Innovations by Chung Min Lee

Introduction

Chung Min Lee is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the purification of proteins. With a total of two patents to his name, Lee's work focuses on enhancing the efficiency and purity of therapeutic proteins.

Latest Patents

One of his latest patents is a method for purifying darbepoetin alfa. This invention relates to selectively separating a structural isoform with a high content of sialic acid from a mixture of isoforms. The method is designed to improve productivity and yield high-purity darbepoetin alfa during mass production. Another significant patent is for a long-acting human growth hormone, known as NexP-hGH. This invention involves a specific isoform of the hormone that is fused with a highly glycosylated alpha-1 antitrypsin mutant, enhancing its long-acting properties in vivo. The purification method for NexP-hGH includes several chromatography steps to ensure high purity.

Career Highlights

Chung Min Lee has worked with prominent companies in the biotechnology sector, including CJ Healthcare Corporation and Alteogen, Inc. His experience in these organizations has contributed to his expertise in protein purification and development.

Collaborations

Lee has collaborated with notable coworkers such as Yoon Jung Lee and Ji Hyun Moon, further enhancing his research and development efforts in the field.

Conclusion

Chung Min Lee's innovative approaches to protein purification have the potential to significantly impact the biotechnology industry. His patents reflect a commitment to improving therapeutic protein production, which can lead to better healthcare solutions.